As we observe Breast Cancer Awareness Month, our focus often centers on promoting early detection, supporting patients, and celebrating the advancements in treatment and research. However, in the age of digitized healthcare, there’s another crucial aspect of the cancer journey that requires our attention: data privacy. As breast cancer patients undergo diagnosis and treatment, they inevitably share a significant amount of personal information with healthcare providers, labs, and other medical institutions. How this data is handled is an issue that deserves as much vigilance as the fight against the disease itself.
A powerful example of why patient data protection matters comes from a case that took place over 70 years ago, long before the digital age, but which continues to resonate today: the story of Henrietta Lacks. Her experience serves as a reminder of how important it is for patients to be aware of how their personal and medical data is used—and why safeguarding that information is essential.
The Henrietta Lacks Case: A Cautionary Tale of Consent and Exploitation
In 1951, Henrietta Lacks, a young African American woman, was diagnosed with cervical cancer at Johns Hopkins Hospital. During her treatment, doctors took a sample of her cancerous cells without her knowledge or consent. These cells, later known as HeLa cells, were found to be incredibly unique: they could replicate endlessly and were vital to numerous medical breakthroughs. HeLa cells contributed to the development of vaccines, cancer treatments, and even in vitro fertilization, but for decades, the Lacks family was unaware of their contribution to medical science.
The issue here wasn’t just the taking of her cells, but the fact that they were used for scientific research and commercial profit without any communication, consent, or compensation. The lack of transparency, the unauthorized use of her biological data, and the impact on her family continue to fuel debates about medical ethics and data privacy to this day.
Although the story of Henrietta Lacks centers on biological material rather than digital data, the core lesson—about the importance of informed consent and the ethical handling of personal information—remains just as relevant for breast cancer patients today as it was in 1951.
-
- Informed Consent is a Fundamental Right:
Henrietta Lacks was never asked if she wanted her cells to be used for research. Today, in a healthcare environment where cancer patients regularly share personal data—such as genetic information or treatment histories—the importance of informed consent cannot be overstated. For instance, under the Jamaica Data Protection Act, the requirements for consent are that it should be informed – persons giving consent must know how their personal data will be processed, the purpose for processing it and with whom the data will be shared; specific – consent related to a particular purpose and activity; unequivocal – there should be no doubt as to what the person is consenting to; freely given – persons must be able to give or withdraw their consent without the threat of a good or service being withheld from them. They should be able to withdraw consent as easily as they provided it.
For cancer patients in Jamaica, where healthcare still operates through a mix of physical and digital records, it’s crucial to understand what happens to personal data once it’s shared. When undergoing genetic testing, for example, patients should be informed about how their genetic data will be stored, who will have access to it, and whether it could be used for research or commercial purposes. Transparency ensures that patients are in control of their health information, preventing exploitation like that seen in the Lacks case.
-
Protecting marginalised communities:
Henrietta Lacks was a poor, African American woman living in an era where race and class often dictated the level of care one received—or didn’t receive. Her case highlights how marginalized communities can be particularly vulnerable to data misuse and exploitation. In the context of cancer care, this lesson is especially important.
In Jamaica, healthcare disparities still exist, with rural and lower-income patients often receiving less access to advanced medical services. These populations may be at greater risk of having their personal health information mishandled or shared without their consent, simply due to the uneven distribution of resources and knowledge. As Jamaica continues to transition toward more digital systems, it’s critical that protections be put in place to ensure all patients, regardless of their background, are safeguarded from misuse of their data.
-
Ethical Use of Data for Research:
One of the enduring issues from the Henrietta Lacks case is the ethical question surrounding the use of patient data or biological materials for research without consent. HeLa cells were shared with researchers and pharmaceutical companies around the world, creating tremendous value for scientific discovery and profit. However, the Lacks family received neither recognition nor compensation for decades.
Today, breast cancer patients should be aware that their medical data—including genetic information—may be used for research. While research is vital to the advancement of cancer treatments, it must be conducted ethically. Patients must be informed and given the choice to participate. In Jamaica’s hybrid healthcare system, where both digital and physical records are used, this means ensuring that all data used for research has the explicit consent of the patient and that they understand how their information will be used.
-
Ethical Use of Data for Research: Henrietta Lacks’ story is, in part, a story of lost trust between the medical community and the Lacks family. The family only learned of the HeLa cells’ legacy years after their mother’s death, and they struggled with the ethical implications of how her cells were used.
For breast cancer patients, trust in the healthcare system is equally vital. Patients need to know that their personal information, whether stored in paper files or digital databases, is being handled securely and ethically. In Jamaica, where not all healthcare facilities have the resources to implement the most advanced data security measures, it’s especially important to ensure that patients are aware of how their data is being protected and are encouraged to ask questions about data security practices.
-
Data Security and Patient Trust:
Henrietta Lacks’ story is, in part, a story of lost trust between the medical community and the Lacks family. The family only learned of the HeLa cells’ legacy years after their mother’s death, and they struggled with the ethical implications of how her cells were used.
For breast cancer patients, trust in the healthcare system is equally vital. Patients need to know that their personal information, whether stored in paper files or digital databases, is being handled securely and ethically. In Jamaica, where not all healthcare facilities have the resources to implement the most advanced data security measures, it’s especially important to ensure that patients are aware of how their data is being protected and are encouraged to ask questions about data security practices.
- Informed Consent is a Fundamental Right:
Applying the Lessons to Jamaica’s Healthcare System
The Henrietta Lacks case highlights the need for vigilance, ethical oversight, and patient empowerment in all matters of healthcare data. For Jamaica, where a mix of physical and digital data is still in use, the challenges of securing personal health information are even more complex. Breast cancer patients share sensitive information during their diagnosis and treatment. Ensuring that this data is handled with care and used ethically is essential to maintaining trust and protecting patient privacy.
As Jamaica continues to implement its Data Protection Act, the lessons from the Henrietta Lacks case can help guide both healthcare providers and patients toward better practices. Healthcare providers must prioritize transparency, informed consent, and secure data handling. For patients, being proactive—asking how their data is stored, who has access to it, and how it’s being used—is key to protecting themselves from misuse:
As we raise awareness for breast cancer this October, let us also raise awareness about the importance of protecting the privacy of those undergoing treatment. The story of Henrietta Lacks shows us that the misuse of personal health information can have lasting consequences for patients and their families. In today’s world, where healthcare data is increasingly digitized, the need for vigilance, ethical practices, and strong legal protections has never been greater.
By learning from the past, we can ensure that cancer patients in Jamaica, and around the world, have their rights respected and their personal information protected, so they can focus on what truly matters: their health and recovery.
As we raise awareness for breast cancer this October, let us also raise awareness about the importance of protecting the privacy of those undergoing treatment. The story of Henrietta Lacks shows us that the misuse of personal health information can have lasting consequences for patients and their families. In today’s world, where healthcare data is increasingly digitized, the need for vigilance, ethical practices, and strong legal protections has never been greater.
By learning from the past, we can ensure that cancer patients in Jamaica, and around the world, have their rights respected and their personal information protected, so they can focus on what truly matters: their health and recovery.
This article was partially generated with the assistance of an AI tool and later reviewed and edited by DataPro Consulting Ltd.
References
Henrietta Lacks Case:
- “The Immortal Life of Henrietta Lacks” by Rebecca Skloot (2010) – This book provides a comprehensive history of Henrietta Lacks’ life, the discovery of HeLa cells, and the ethical issues surrounding her case.
- Johns Hopkins Medicine’s official Henrietta Lacks page: https://www.hopkinsmedicine.org/henriettalacks/ – This page provides an official summary of Henrietta Lacks’ contributions to science and the ongoing discussions about ethical concerns.
- National Institutes of Health (NIH): Information about the NIH’s ongoing policies regarding the use of HeLa cells in research: https://www.nih.gov/news-events/news-releases/nih-honors-contribution-henrietta-lacks-hela-cell-research
General Data Privacy and Consent:
- Our website: For further information on privacy and data protection refer to our website www.dataprocaribbean.com/resources and sign up for our Newsletter.
Healthcare Data Protection and Ethical Issues:
- World Health Organization (WHO) on Informed Consent in Healthcare: This source provides guidelines on informed consent and patient rights in medical research: https://www.who.int/ethics/informed-consent/en/
- British Medical Journal (BMJ): Ethical considerations for data privacy in healthcare: https://www.bmj.com/about-bmj/resources-readers/publications/privacy-patients
